Evidence map›Paper›PMID 36267522›Full record

ArticleJournal of clinical & experimental dermatology research2016

Somatic Mosaicism in Blaschkolinear Inflammatory Disorders.

Nicholas Theodosakis, Lauren Levy, Shawn Cowper, Rossitza Lazova, Lisa Kugelman, Amanda Zubek, Keith Choate

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical & experimental dermatology research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Nicholas TheodosakisDepartment of Dermatology, Yale School of Medicine, New Haven, CT, USA.
Lauren LevyDepartment of Dermatology, Yale School of Medicine, New Haven, CT, USA.
Shawn CowperDepartment of Dermatology, Yale School of Medicine, New Haven, CT, USA.
Rossitza LazovaDepartment of Dermatology, Yale School of Medicine, New Haven, CT, USA.
Lisa KugelmanDepartment of Dermatology, Yale School of Medicine, New Haven, CT, USA.
Amanda ZubekDepartment of Dermatology, Yale School of Medicine, New Haven, CT, USA.
Keith ChoateDepartment of Dermatology, Yale School of Medicine, New Haven, CT, USA.
Yale University · US

Funding

Medical Scientist Training ProgramT32GM136651 · NIGMS · YALE UNIVERSITY · PI BARBARA I KAZMIERCZAK · 2020 to 2026
$16.5M
Evaluation of BRAF-inhibitor induced alterations in glucose metabolismF30CA180591 · NCI · YALE UNIVERSITY · PI THEODOSAKIS, NICHOLAS · 2013 to 2015
$143k
NCI NIH HHS F30 CA180591NIGMS NIH HHS T32 GM136651
6 · The paper itself

Abstract

Linear lichen planus (LP) is a rare dermatologic disease in which lichenoid lesions conform to a blaschkolinear distribution, most commonly on the extremities. Linear discoid lupus erythematosus (DLE) is a cutaneous manifestation of lupus that also conforms to Blaschko's lines. Blaschkolinear disorders have been shown to result from somatic mosaicism, most recently in nevus sebaceus, epidermal nevi, and syringocystadenoma papilliferum. In linear LP and DLE, presentation of papules along Blaschko's lines suggests that these disorders can result from keratinocytic genetic mosaicism. Their onset later in life suggests that a secondary trigger is necessary to drive inflammatory reactions to these linear lesions. To date causative mutations have not be identified. We report 2 cases of linear lichen planus and 1 case of linear discoid lupus erythematosus, all histologically confirmed. Both LP patients have experienced episodic regression and recurrence of their lesions in precisely the same distribution, with moderate symptomatic benefit from topical steroids and non-steroidal anti-inflammatories. The DLE patient showed gradual response to hydroxychloroquine over the course of 14 months. These cases highlight linear inflammatory diseases which represent localized variants of disorders for which there are few efficacious therapies. Their linear presentations suggest that they result from somatic mosaicism and genetic investigation of such disorders may reveal relevant therapeutic targets.

Indexed as

BlaschkolinearGenodermatosesLinear

Identifiers

PMID36267522
PMCPMC9581078
OpenAlexW2515153322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.